K-Zithirin 500
K-Zithrin is for LRTIs, Sinusits, Urogenital infections, Skin and soft tissue infections and acute otitis media.
- Unique kinetics:Moves rapidly from blood to tissues and stays there for prolonged time.
- Post antibiotic effect:Targeted activity at the site of infection, remains at site of infection for 5-7 days after the last dose.
- Excellent spectrum:Gram +ve and Gram -ve aerobes and anaerobes and intracellular pathogens.
- Beats the rest:Best among macrolides against H. influenzae.
- Generic Name : Azithromycin
- Strength: 500mg
- Available Pack Size: 3’s (3’s Blister x 1)
PediaCare
Key Benefits:
- Supports growth and development: Pediacare contains high-quality protein, calcium, and vitamin D. The regular consumption of this drink with a well-balanced, healthy diet could help one gain weight and height.
- Immune support: Pediacare supports immunity with antioxidant compounds such as selenium, Zinc and vitamins A, C and E.
Available pack size: 400gm & 900gm Tins (Vanilla Flavor)
Shelf Life: 24 Months
Kidzvit Syrup
Improves physical and mental stamina.
- promotes rapid growth and help combat infections
- Boosts immune system.
- Promote bone density.
OROLYTE 4.40g & 21.80g
It is a Oral Rehydration Salts, which is a mixture of sugar and salts.
Key Benefits
- It is recommended for the replacement of fluids and electrolytes lost during diarrhoel illness and other cases of dehydration.
- Sugar provides necessary calories,at the same time along with the electrolytes, enhances the transport of water across the intestinal barrier through osmosis.
Available Pack sizes: 10’s (10 x 4.40g sachets)
10’s (10 x 21.80g sachets)
Available Flavors: Lemon & Orange , Pineapple, Orange
Alkal is a Urinary Alkalizer
ALKAL EFFERVESCENT GRANULES
Key Benefits:
It is indicated in the treatment of urinary tract infection, symptomatic relief of dysuria, and in gout therapy to prevent crystallization of urates.
- Pack size: 10’s (10 x 4g Sachets)
- Shelf Life: 24 Months
KUFFY SYRUP
Indications:
– Kuffy relieves cough and cold.
– Boosts the immune system.
- Pack Size: 120mL Glass Bottle
- Dispensing mode: Pharmacy Only (P)
- Shelf Life: 24 Months
Wincoff Syrup
Key Benefits:
- Cough, Cold, and Sore throat.
- Allergic rhinitis
- Chronic sinusitis
- Offers prompt relief from a variety of symptoms, including congestion chest, and the flu.
- Anti-Inflammatory
- Bronchitis
- Available pack size: 100 ML Glass Bottle Syrup
- Shelf Life: 24 Months
- Registration Status: Registration completed and Commercialized
LCIN 500
LCin 500 contains the active ingredient levofloxacin. Levofloxacin is a quinolone antibiotic. It works by killing the bacteria that cause infection in your body.
LCin 500 can be used in adults including elderly to treat infections of the:
- Sinuses
- Lungs, in people with long-term breathing problems or pneumonia
- Urinary tract, including your bladder or kidneys.
- Skin and underneath the skin, including muscles. This is sometimes called ‘soft tissue’.
- Prostate gland, where you have a long-lasting infection.
In some special situations, L-Cin 500 may be used to lessen the chances of getting a pulmonary disease named anthrax or worsening of the disease after you are exposed to the bacteria causing anthrax.
- Generic Name: Levofloxacin
- Dosage Form: Tablets
- Strength: 500mg
- Pack Size: 7’s (1×7’s)
Diavit
Indication:
DIAVIT is a health supplement containing vitamins and minerals specially formulated to combat oxidative stress and improve quality of life.
- Pack Size: 30’s (3×10’s Blister)
- Shelf Life: 24 Months
- Registration Status: Registration completed and Commercialized
(Orange & Raspberry Flavor) EFFERVESCENT TABLETS
MAX VITAMIN C
Key Benefits:
- Vitamin C is a powerful antioxidant that can strengthen your body’s natural defenses.
- Vitamin C supplements boost immunity, as vitamin C is involved in many parts of the immune system.
Active Ingredients:
- Each Film Coated Tablet contains:
- L-Ascorbic Acid – 1000mg
- Available pack size: 20 Effervescent Tablets
- Shelf Life: 24 Months
- Registration Status : Registration done and to be commercialized
Fetab Forte
FETAB FORTE TABLETS are haematinic health supplements to assist in red blood cell formation and the maintenance of good health.
- Dosage Form: Film coated Tablet
- Strength: 500mg
- Pack Size: 30’s (3×10’s Blister)
- Dispensing mode: Pharmacy Only (P)
FibreGut Powder
Indications:
- Alleviates constipation
- Improves Gut Sensitivity
- Supports digestive health
Active Ingredients:
- Hydrolyzed Guar Gum
- L-Theanine
- Registration status: Registration completed and commercialized
- Shelf Life: 24 Months
- Dispensing Mode: Pharmacy Only
DYPSTA 80/5 mg and 80/10 mg
Indication:
- Dypsta tablets contain two active substances called telmisartan and amlodipine. Both of these substances help to control your high blood pressure
- Pack Size: 30’s (3×10’s Blister)
- Shelf Life: 36 Months
- Registration Status: Registration completed and In final stage of Commercialization
DYPSTA 40/5 mg DYPSTA 40/10 mg
Indication:
Dypsta tablets contain two active substances called telmisartan and amlodipine. Both of these substances help to control your high blood pressure
- Pack Size: 30’s (3×10’s Blister)
- Shelf Life: 36 Months
- Registration Status: Registration completed and In final stage of Commercialization
- Dispensing mode: Pharmacy Only (P)
Telmisartan
Melista
Indication:
- Telmisartan belongs to a class of medicines known as angiotensin II receptor antagonists.
- Angiotensin II is a substance produced in your body which causes your blood vessels to narrow, thus
- Increasing your blood pressure. Telmisartan blocks the effect of angiotensin II so that the blood vessels relax, and your blood pressure is lowered
- Pack Size: 30’s (3×10’s Blister)
- Available pack size: 30’s (10X3)
- Shelf Life: 24 Months
- Registration Status: Registration completed and In final stage of Commercialization
DHA
DDC – Available
EBP – False
DOH
HAAD – Pending
AD basic plan – Pending
supplement for healthy functioning of thyroid gland
TNORM Tablets
Key Benefits:
- Helps to normalize thyroid hormones.
- Improves physical Stamina.
- Tackles insomnia, Stress, and Anxiety.
- Controls overall metabolic pathways.
- Antioxidant activity.
Active Ingredients;
Inositol -600mg
Nicotinamide-32mg
L-Selenomethionine-100µg
Potassium Iodide-150 µg
Pantothenic Acid-12mg
Pyridoxine Hydrochloride(Vit B6)-2.8mg
Riboflavin-2.8mg
Thiamin Hydrochloride-2.2mg
Cyanocobalamin (Vit-B12)-5 µg
D-Bioitin -100 µg
Pantoprazole 40 mg
Nupenta
Indication:
- Pantoprazole reduces the amount of acid your stomach makes.
- It’s used for heartburn, acid reflux and gastro-oesophageal reflux disease (GORD) – GORD is when you keep getting acid reflux.
- It’s also taken to prevent and treat stomach ulcers.
Pack Size – 28’s (7’s Blister x 4)
Registration Status – Registration done and to be commercialized
Ondansetron Injection 2mg/ml
Dantron
Indication:
- Ondansetron injection is used to prevent nausea and vomiting caused by cancer medicines (chemotherapy or radiation), including high-dose cisplatin.
- This medicine is also used to prevent and treat nausea and vomiting that may happen after surgery
Pack size – 10 Vials (2x5x2ml)
K ZITHRIN 500
Pediacare 900gm
LCIN 500
Alkal Effervescent Granules
Kuffy Syrup
Orolyte
Fetab Forte
Diavit
Wincoff Syrup
Kidzvit Syrup
Fibregut Powder
Max Vitamin C Effervescent Tablets
Dypsta 40/5 mg
Dypsta 40/10 mg
Dypsta 80/5 mg
Dypsta 80/10 mg
Tnorm
Melista 80mg
Melista 40mg
K ZITHRIN 500
Pediacare 900gm
LCIN 500
Alkal Effervescent Granules
Kuffy Syrup
Orolyte
Fetab Forte
Diavit
Wincoff Syrup
Kidzvit Syrup
Fibregut Powder
Max Vitamin C Effervescent Tablets
Dypsta 40/5 mg
Dypsta 40/10 mg
Dypsta 80/5 mg
Dypsta 80/10 mg
Tnorm
Melista 80mg
Melista 40mg
Additional Products
GENERAL INJECTABLE ▼
| Sl. No. | Products | Dossier Readiness |
|---|---|---|
| 1 | Propofol Injectable Emulsion 10mg/ml / 20mg/ml | YES |
| 2 | Hydrocortisone Sodium Succinate for Injection 100mg/Vial | YES |
| 3 | Sodium Bicarbonate Injection 8.4% | YES |
| 4 | Alprostadil for Injection 10mcg / 20mcg | YES |
| 5 | Labetalol Hydrochloride Injection 5mg/ml | YES |
| 6 | Omeprazole for Injection 40mg/Vial | YES |
| 7 | Tenoxicam for Injection 20mg (Lyophilized) | YES |
| 8 | Fosfomycin Sodium for Injection 1/4g | UNDER DEVELOPMENT |
| 9 | Aprotinin Injection 10000 KIU (Lyophilized) | YES |
| 10 | Lidocaine Hydrochloride Injection 2% | YES |
| 11 | Bupivacaine Injection 2% | YES |
| 12 | Betamethasone Sodium Phosphate Injection 4mg/1ml | YES |
| 13 | Paracetamol Injection 500mg | YES |
| 14 | Dobutamine Injection 12.5mg/ml | YES |
| 15 | Acyclovir Injection 250mg / 500mg / 1g | YES |
| 16 | Phloroglucinol Injection 10mg/ml | YES |
| 17 | Ketorolac Tromethamine Injection 30mg/ml | YES |
| 18 | Diclofenac Injection 50mg | YES |
| 19 | Hydralazine Injection 20mg/ml | YES |
| 20 | Amphotericin B Liposomal Injection 50mg (BE Study Planned Q4 2025) | YES |
| 21 | Paricalcitol Injection 5mcg/ml | YES |
| 22 | Isosorbide Injection 1mg/ml | YES |
| 23 | Ferric CarboxyMaltose Injection 50mg/ml | YES |
| 24 | Nitroglycerin Injection 5mg/ml | YES |
| 25 | Nicardipine Injection 1mg/ml & 2.5mg/ml & 2mg/ml | YES |
| 26 | Norepinephrine Injection 1mg/ml & 2mg/ml | YES |
NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES (CONTROL SUBSTANCE) ▼
| Sl. No. | Products | Dossier Readiness |
|---|---|---|
| 1 | Ketamine Hydrochloride Injection 10mg/ml | YES |
| 2 | Morphine Sulphate Injection 10mg/ml | YES |
| 3 | Fentanyl Citrate Injection 50mcg/ml | YES |
| 4 | Midazolam Injection 5mg/ml | YES |
| 5 | Remifentanil Hydrochloride for Injection 1mg / 2mg / 5mg | YES |
| 6 | Sufentanil Citrate Injection 5mcg/ml | YES |
| 7 | Phenobarbitone Injection 200mg/ml | YES |
DENTAL CARTRIDGES ▼
| Sl. No. | Products | Dossier Readiness |
|---|---|---|
| 1 | Lidocaine and Epinephrine Injection 1% w/v & 1:200000 | YES |
| 2 | Articaine and Epinephrine Injection 40mg + 1:100000/ml | YES |
OPHTHALMICS (ANVISA Planned by Q1 2026) ▼
| Sl. No. | Products | Dossier Readiness |
|---|---|---|
| 1 | Dorzolamide + Timolol 20mg + 5mg/ml | YES |
| 2 | Brimonidine 0.2% | YES |
| 3 | Timolol 0.25% / 0.3% | YES |
| 4 | Ciprofloxacin + Dexamethasone 0.3% + 0.1% | YES |
| 5 | Bimatoprost 0.03% / 0.1% | YES |
| 6 | Brimonidine 0.2% Solution | UNDER DEVELOPMENT |
| 7 | Brinzolamide + Timolol | YES |
BETA LACTAM - INJECTABLE ▼
| Sl. No. | Products | Dossier Readiness |
|---|---|---|
| 1 | Meropenem for Injection 500mg / 1000mg | YES |
| 2 | Amoxicillin for Injection 500mg / 1000mg | YES |
| 3 | Amoxicillin + Potassium Clavulanate for Injection 500mg + 100mg | YES |
| 4 | Amoxicillin + Potassium Clavulanate for Injection 1000mg + 200mg | YES |
| 5 | Ertapenem Sodium for Injection 1g | YES |
| 6 | Imipenem + Cilastatin 500mg + 500mg | Q4 2025 |
| 7 | Aztreonam 1g | YES |
| 8 | Piperacillin + Tazobactam 4.5g | YES |
BETA LACTAM - ORAL SOLIDS ▼
| Sl. No. | Products | Dossier Readiness |
|---|---|---|
| 1 | Amoxicillin + Potassium Clavulanate 875mg + 125mg | Q1 2026 (with BE study) |
| 2 | Amoxicillin + Potassium Clavulanate 500mg + 125mg | Q1 2026 (with BE study) |
| 3 | Sultamicillin Tablet 375mg / 750mg | UNDER DEVELOPMENT |
CEPHALOSPORINS - INJECTABLE ▼
| Sl. No. | Products | Dossier Readiness |
|---|---|---|
| 1 | Ceftriaxone for Injection 1g | YES |
| 2 | Cefixime for Injection 1g | YES |
| 3 | Cephalothin Injection 1g | YES |
| 4 | Ceftriaxone + Sulbactam 1.5g | YES |
ONCOLOGY - INJECTABLE ▼
| Sl. No. | Products | Dossier Readiness |
|---|---|---|
| 1 | Azacitidine for Injection 100mg (BE by Mar 2026) | YES |
| 2 | Zoledronic Acid for Injection 4mg | YES |
| 3 | Leucovorin Calcium 50mg / 100mg | YES |
| 4 | Irinotecan 100mg | YES |
| 5 | Idarubicin 5mg | YES |
| 6 | Bleomycin 15 EU | YES |
| 7 | Doxorubicin Hydrochloride Liposomal Injection 20mg | YES |
| 8 | Docetaxel 80mg / 2ml | YES |
| 9 | Paclitaxel (Protein Bound) 100mg | YES |
| 10 | Fluorouracil Injection 100mg/ml | YES |
| 11 | Triptorelin Pamoate 11.25mg | YES |
| 12 | Leuprolide Acetate Depot for Injection 3.75mg / 7.5mg / 11.25mg / 22.5mg (Lyophilized) | YES |
| 13 | Octreotide Acetate Long Acting Release Injection 20mg / 30mg (Lyophilized) | YES |
ONCOLOGY - ORAL SOLIDS ▼
| Sl. No. | Products | Dossier Readiness |
|---|---|---|
| 1 | Abiraterone Acetate Tablets 250mg (with BE Study) | YES |
| 2 | Tamoxifen 20mg | YES |
| 3 | Sunitinib Capsule 50mg | Q1 2026 (with BE study) |
| 4 | Nilotinib Capsules 150mg / 200mg | Q4 2025 (with BE study) |
| 5 | Hydroxycarbamide Capsules 500mg | Q4 2025 (with BE study) |